Charles Cohen
13Patents
3h-index
32Co-inventors
60Inventor score
Filing activity: Aug 6, 1998 → Nov 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10246453B2 | Benzenesulfonamide compounds and their use as therapeutic agents | Chemistry; Metallurgy | 8 | Active |
| US6358701B1 | DNA molecules encoding Ctenocephalides felis glutamate gated chloride channels | Chemistry; Metallurgy | 6 | Expired |
| US10233219B2 | Methods and systems for designing and/or characterizing soluble lipidated ligand agents | Physics | 4 | Active |
| US11197906B2 | Methods of lowering blink reflex for the treatment of dry eye disease | Human Necessities | 2 | Active |
| US11254720B2 | Methods and systems for designing and/or characterizing soluble lipidated ligand agents | Physics | 2 | Active |
| US10662184B2 | Benzenesulfonamide compounds and their use as therapeutic agents | Chemistry; Metallurgy | 2 | Active |
| US11174268B2 | Benzenesulfonamide compouds and their use as therapeutic agents | Chemistry; Metallurgy | 2 | Active |
| US7888384B2 | Heterocyclic derivatives for modulation of calcium channels | Human Necessities | 1 | Active |
| US11299490B2 | Benzenesulfonamide compounds and their use as therapeutic agents | Chemistry; Metallurgy | 1 | Active |
| US12060397B2 | Soluble lipidated ligand agents for treating eye inflammation | Physics | 0 | Active |
| US7569604B2 | Heterocyclic derivatives for modulation of calcium channels | Human Necessities | 0 | Expired |
| US12053501B2 | Methods for treating symptoms of dry eye disease | Human Necessities | 0 | Active |
| US8211935B2 | Heterocyclic derivatives for modulation of calcium channels | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.